"SPEEDING SAFE AND EFFECTIVE CANCER TREATMENTS TO PATIENTS IS OUR ONLY MISSION"
Enrollment for the 2017 AAADV Workshop will open February 1, 2017

May 3-5, 2017

AAADV not only impacts the rate at which oncology drugs are brought to market, but patients afflicted with cancer have been able to appreciate significant advances in their care and survival rates.

Richard Pazdur

Director, Office of Hematology and Oncology Drug Products

U.S. Food and Drug Administration Center for Drug Evaluation and Research

Moonshot Task Force Director Addresses AAADV Workshop

Greg Simon, executive director of the cancer moonshot task force, addressed the FDA-sponsored workshop for Accelerating Anticancer Agent Development and Validation in North Bethesda, Md., May 4.

He discussed the goals for the moonshot initiative, how the program could fit into the next presidential administration, and how to take the project international.

Simon was a former aide to Vice President Al Gore, and later helped start FasterCures, a center at the Milken Institute. In 2009, he left to become senior vice president for patient engagement at Pfizer. Since 2012, he has been working as CEO of Poliwogg, a financial services company focused on life sciences. He was named executive director of the moonshot’s task force in March.

An excerpt of Simons’ remarks

Workshop 2016 Gallery

Programs

AAADV Workshop

Leaders in clinical and translational cancer research from academia, industry, government and the nonprofit advocacy sector focus on understanding and efficiently negotiating the drug development process.

May 3-5, 2017

Learn More

 

AAADV Scholars

Pre-workshop for Clinical and Translational Investigators

May 2, 2017

Learn More

 

AAADV Fundamentals

In collaboration with Susan G. Komen

Pre-workshop for Patient Advocates

May 1-2, 2017

Learn More

 

Speakers

 

Subscribe


Please Wait!

Location

Twitter Feed


TWEET WITH THE HASHTAG #AAADV2016


AAADV Mobile app coming soon for Android and iOS

app-store-imagegoogle-play-image